(VIANEWS) - Westamerica Bancorporation (WABC), Exelixis (EXEL), Central Valley Community Bancorp (CVCY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Westamerica Bancorporation (WABC)
48.9% sales growth and 15.16% return on equity
Westamerica Bancorporation is a holding bank for Westamerica Bank. It provides various banking services and products to individuals and businesses. It accepts deposits from all types, such as checking and retail savings accounts as well as certificates. The company's loan portfolio includes residential, commercial, and residential real property, construction and consumer loans. It also offers loans that primarily include indirect auto loans. Westamerica Bancorporation has 79 branches in 21 California counties. The former name of the company was Independent Bankshares Corporation. In 1983, it changed its name from Westamerica Bancorporation. Westamerica Bancorporation is located in San Rafael in California. It was established in 1972.
Earnings Per Share
As for profitability, Westamerica Bancorporation has a trailing twelve months EPS of $3.88.
PE Ratio
Westamerica Bancorporation has a trailing twelve months price to earnings ratio of 14.49. Meaning, the purchaser of the share is investing $14.49 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.16%.Dividend Yield
Morningstar, Inc. claims that the next dividend payment will be on November 3, 2022. The forward dividend rate and yield are both 1.68 and 2.99%, respectively.
Sales Growth
Westamerica Bancorporation's sales growth is 47.8% for the present quarter and 48.9% for the next.
Moving Average
Westamerica Bancorporation's value is under its 50-day moving average of $59.26 and under its 200-day moving average of $58.38.Revenue Growth
Year-on-year quarterly revenue growth grew by 32.1%, now sitting on 239.14M for the twelve trailing months.
2. Exelixis (EXEL)
20% sales growth and 13.36% return on equity
Exelixis, Inc., is an American biotech company that focuses exclusively on oncology. It aims to develop, commercialize, and market new treatments for cancer in the United States. CABOMETYX is a tablet that treats advanced renal cell carcinoma patients who have received anti-angiogenic treatment. COMETRIQ capsules are used to treat patients suffering from metastatic and progressive medullary Thyroid Cancer. The company's COMETRIQ and CABOMETYX are derived form cabozantinib which is an inhibitor of many tyrosine kinases including MET and AXL. COTELLIC is an inhibitor of MEK that can be used in combination with COMETRIQ to treat advanced melanoma. MINNEBRO is an oral, non-steroidal, selective blocker for the mineralocorticoid receptor. This treatment will help reduce hypertension in Japan. It is also developing XL092, an oral tyrosine kinase inhibiter that targets VEGF receptors and MET. Exelixis, Inc. is a member of the following research partnerships and licensing agreements: Ipsen Pharma SAS, Takeda Pharmaceutical Company Ltd., F. Hoffmann-La Roche Ltd., Redwood Bioscience, Inc., R.P. Scherer Technologies, LLC, Catalent Pharma Solutions, Inc., F. Hoffmann-La Roche Ltd., Redwood Bioscience, Inc., and Iconic Therapeutics, Inc. Genentech, Inc., Bristol-Myers Squibb Company, and Daiichi Sankyo Company, Limited. The former name of the company was Exelixis Pharmaceuticals, Inc., but it changed its name in February 2000 to Exelixis, Inc. Exelixis, Inc., was founded in 1994. It is located in Alameda, California.
Earnings per Share
Exelixis' trailing twelve-month EPS is $0.97.
PE Ratio
Exelixis' trailing 12-month price-to-earnings ratio is 16.54. The purchaser of the shares is investing $16.54 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 13.36%.Moving Average
Exelixis is worth less than its moving average 50 days of $16.43 per day and much lower than its moving average 200 days of $18.90.3. Central Valley Community Bancorp (CVCY)
18.8% sales growth and 12.75% return on equity
Central Valley Community Bancorp is the bank holding firm for Central Valley Community Bank. It provides various banking services to individuals and small businesses in the Central Valley area. It accepts time, demand and savings deposits, NOW and money markets accounts, certificates of deposit, as well as non-interest bearing demand deposits. The company offers loans in commercial and industrial, as well as loan secured by crop production or livestock, owner-occupied real property, land construction, other land, agriculture real estate and other loans. Equity loans and credit lines, installment loans and consumer loans are some of its products. It also provides domestic and international wire transfers, safe deposit boxes, Internet banking and other traditional banking services. The company had 20 fully-service banks offices as of December 31, 2020 in Cameron Park and Clovis. Central Valley Community Bancorp, which was established in 1979 in Fresno California is the headquarters.
Earnings Per Share
As for profitability, Central Valley Community Bancorp has a trailing twelve months EPS of $2.19.
PE Ratio
Central Valley Community Bancorp has a trailing twelve months price to earnings ratio of 9.67. Meaning, the purchaser of the share is investing $9.67 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.75%.Revenue growth
The year-on-year revenue growth was 1.4%. We now have 83.14M in the 12 trailing months.
4. Acadia Healthcare Company (ACHC)
11.4% sales growth and 10.99% return on equity
Acadia Healthcare Company, Inc. is a developer and operator of inpatient and residential psychiatric centers, residential treatment centres, group homes, substance abuse and outpatient behavioral healthcare services to meet the needs of the communities in Puerto Rico and the United States. It operates an acute inpatient mental health facility that stabilizes patients who are either a threat to their lives or require 24-hour monitoring, intervention and supervision by psychiatrists. The company also has specialty treatment facilities that include residential treatment and eating disorder facilities and holistic treatment centers which provide continuous care for people with co-occurring mental and addictive disorders. The company also offers residential treatment centers that treat behavioral disorders and provide therapeutic placements for adolescents and children with emotional disorders. It had approximately 10500 beds in 228 of its behavioral health facilities as of February 28, 2022. Acadia Healthcare Company, Inc. is located in Franklin, Tennessee.
Earnings per Share
Acadia Healthcare Company's trailing 12 months profit per share was $-7.91
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 10.99%.Yearly Top and Bottom Value
Acadia Healthcare Company's stock is valued at $81.57 at 05:22 EST, below its 52-week high of $89.85 and way above its 52-week low of $50.07.
Volume
Today's last reported volume for Acadia Healthcare Company is 66702 which is 89.47% below its average volume of 633714.
Sales Growth
Acadia Healthcare Company's sales growth for the next quarter is 11.4%.
5. Reynolds Consumer Products (REYN)
10.6% sales growth and 15.87% return on equity
Reynolds Consumer Products Inc. manufactures and markets products for the cooking, waste, storage and tableware categories. There are four main segments to it: Reynolds Cooking & Baking; Hefty Waste & Storage; Hefty Tableware; and Presto Products. Reynolds Cooking & Baking produces foil, aluminum pans, paper for baking, paper for freezer, paper for cooking, paper for wrapping food in, paper bags and paper wrap for slow cookers. It is also available under Reynolds Wrap, Reynolds KITCHENS and E-Z Foil brand names in the United States. Hefty Waste & Storage offers garbage bags and food storage bags, both under the Hefty Ultra Strong or Hefty Strong brand. The Hefty EnergyBag program, which includes blue, clear, plastic, recyclable, compostable, and bags made of recycled materials, is also available in this segment. Hefty Tableware offers disposable and compostable dishes, plates, bowls and platters as well as cutlery. Presto Products sells plastic wrap, food storage bags and trash bags. Reynolds Consumer Products Inc. sells both store and brand-name products to supermarkets, bulk merchants, warehouse clubs and discount chains. They also offer dollar stores and drug stores as well as home improvement and military stores. It was established in 1947 in Lake Forest, Illinois. Reynolds Consumer Products Inc. is a subsidiary to Packaging Finance Limited.
Earnings per Share
Reynolds Consumer Products' trailing 12 month EPS is $1.58.
PE Ratio
Reynolds Consumer Products' trailing 12-month price-to-earnings ratio is 19.23. The purchaser of the shares is therefore investing $19.23 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 15.87%.Growth Estimates Quarters
The company's growth estimates for the ongoing quarter is a negative 30.3% and positive 19.6% for the next.Moving Average
Reynolds Consumer Products's market value is lower than its $50.49 moving average and higher than its $200 moving average $28.76.Sales Growth
Reynolds Consumer Products's sales growth is 11.3% for the current quarter and 10.6% for the next.
Dividend Yield
Morningstar, Inc. estimates that the next dividend payment will be on August 15, 2022. The forward annual dividend rate for the year is 0.92, and the forward annual dividend yield of 3.06%.
6. Legacy Housing Corporation (LEGH)
6% sales growth and 18.73% return on equity
Legacy Housing Corporation builds, sells, and finances manufactured homes and tiny houses primarily in the southern United States. The company manufactures and provides for the transport of mobile homes; and offers wholesale financing to dealers and mobile home parks, as well as a range of homes, including 1 to 5 bedrooms with 1 to 3 1/2 bathrooms. It also provides floor plan or wholesale financing for independent retailers; consumer financing for its products; and financing to manufactured housing community owners that buy its products for use in their rental housing communities. The company markets its homes under the Legacy brand through a network of 100 independent and 13 company-owned retail locations, as well as direct sales to owners of manufactured home communities in 15 states in the United States. Legacy Housing Corporation was founded in 2005 and is headquartered in Bedford, Texas.
Earnings Per Share
As for profitability, Legacy Housing Corporation has a trailing twelve months EPS of $2.38.
PE Ratio
Legacy Housing Corporation has a trailing twelve months price to earnings ratio of 7.56. Meaning, the purchaser of the share is investing $7.56 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.73%.Sales Growth
Legacy Housing Corporation has seen a 15.5% increase in sales for its current quarter, and an additional 6% the following.
Volume
Legacy Housing Corporation's current reported volume is 32510, which is 25.02% less than its average volume at 43362.
Moving Average
Legacy Housing Corporation's value is above its 50-day moving average of $17.49 and higher than its 200-day moving average of $17.33.Earnings before Interest, Taxes and Depreciation
Legacy Housing Corporation has an EBITDA of 1.92.